A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/25/2004	US20040234977 Comprises enzymatic polypeptide for use as diagnostic indicator of injury or disease associated with brain, liver and muscle tissue; immunoassay
11/25/2004	US20040234969 Using cytochrome p450 gene expression as diagnostic indicator of steroid responsiveness; identifying modulators for treatment and prevention of skin and allergic disorders
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234666 Method of extracting casein fractions from milk and caseinates and production of novel products
11/25/2004	US20040234626 Food supplement for increasing lean mass and strength
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234616 Long acting injectable insulin composition and methods of making and using thereof
11/25/2004	US20040234615 Oral insulin composition and methods of making and using thereof
11/25/2004	US20040234609 Repeat sequence protein polymer active agent congjugates, methods and uses
11/25/2004	US20040234579 Self life; adjuvant mixed with carrier matrix; molding; freeze drying
11/25/2004	US20040234572 Preparation of sustained release pharmaceutical composition
11/25/2004	US20040234542 Immunoassay; open reading frame protein; detecting antibodies
11/25/2004	US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234532 Methods and compositions for treating eye disorders
11/25/2004	US20040234528 Binding, neutralization respiratory syncytial virus antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234525 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/25/2004	US20040234523 Antiischemic agents; synergistic mixture of interleukin inhibitor and tumor necrosis factor antagonist
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234520 Uses for Eph receptor antagonists and agonists
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234517 Prevent gene expression of arginine in metabolism in tissue; arginase inhibitors
11/25/2004	US20040234515 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor
11/25/2004	US20040234514 Compositions and methods for treating or preventing oxalate-related disease
11/25/2004	US20040234513 Composition and method for reducing blood glucose
11/25/2004	US20040234502 Method for treatment of vascular regeneration
11/25/2004	US20040234501 administering lamivudine; suppression reproduction of hepatitis virus; interferons
11/25/2004	US20040234500 Method for inducing proliferation of retinal stem cells
11/25/2004	US20040234499 Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040234481 Gene transfers of angiogenic factor for skin disease
11/25/2004	US20040234461 studying cell wall of oral bacterium; prevent oral diseases; anticaries agents; remove dextran from tooth surrface
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	US20040234312 Bit mask generation system
11/25/2004	US20040232205 Lantibiotic
11/25/2004	DE10320781A1 Acylierte Nonadepsipeptide Acylated nonadepsipeptides
11/25/2004	CA2557615A1 Treatment of haemorrhagic shock using complement 5a receptor inhibitors
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525568A1 Novel peptides that bind to the erythropoietin receptor
11/25/2004	CA2525539A1 Treatment kit to assist in antibiotic therapy in intracellular infectious diseases
11/25/2004	CA2525522A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	CA2525497A1 Peptides that bind to the erythropoietin receptor
11/25/2004	CA2525496A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	CA2525464A1 Novel poly(ethylene glycol) modified compounds and uses thereof
11/25/2004	CA2525107A1 Novel fibroblast growth factors and methods of use thereof
11/25/2004	CA2525049A1 Insoluble globin injectable implant
11/25/2004	CA2524882A1 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	CA2524847A1 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases
11/25/2004	CA2524816A1 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
11/25/2004	CA2524456A1 Apo2l (trail) receptor binding peptides and uses thereof
11/25/2004	CA2524444A1 A method for altering insulin pharmacokinetics
11/25/2004	CA2524403A1 Active variants of the il-18 binding protein and medical uses thereof
11/25/2004	CA2523943A1 Compositions and methods for wt1 specific immunotherapy
11/25/2004	CA2523477A1 Stabilized liquid protein formulations in pharmaceutical containers
11/25/2004	CA2522404A1 One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes
11/25/2004	CA2518608A1 Antimicrobial peptide and methods of use thereof
11/24/2004	EP1480445A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same
11/24/2004	EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479711A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it
11/24/2004	EP1479697A1 Tick chitinase
11/24/2004	EP1479696A1 Human monoclonal antibody binding Ep-CAM, and its use in cancer therapy
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1479691A1 Long lasting fusion peptide inhibitors for HIV infection
11/24/2004	EP1479689A1 Peptide complex
11/24/2004	EP1479682A1 Immunosuppressive effects of pteridine derivatives
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1479396A1 Drugs ameliorating circadian rhythum disorder
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1479394A1 The use of epidermal growth factor (EGF) for increasing weight gain in an animal
11/24/2004	EP1479393A1 Stabilized albumin preparations
11/24/2004	EP1478927A2 Macromolecular conjugates and processes for preparing same
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478769A2 Phytases, nucleic acids encoding them and methods for making and using them
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478758A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
11/24/2004	EP1478752A2 Human chemokine-13
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478745A2 Kinases and phosphatases
11/24/2004	EP1478744A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
11/24/2004	EP1478743A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/24/2004	EP1478741A1 Combination of a growth factor and a protease enzyme
11/24/2004	EP1478740A2 Heteromultimeric tnf ligand family members
11/24/2004	EP1478732A1 A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug
11/24/2004	EP1478730A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/24/2004	EP1478667A1 Anti-human tenascin monoclonal antibody
11/24/2004	EP1478666A2 Dermopharmaceutically and cosmetically active oligopeptides
11/24/2004	EP1478665A2 Organic compounds having anti-angiogenic activity
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1478660A2 KAPPA−PVIIA−RELATED CONOTOXINS AS ORGAN PROTECTANTS
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478658A2 Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors
11/24/2004	EP1478655A2 METHODS AND MATERIALS FOR MODULATING ENaC-BETA
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478393A2 Anti-pathogen treatements
11/24/2004	EP1478392A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 3163